SHL announces updated invitation to the Special General Meeting

Tel Aviv / Zurich - April 10, 2018 - SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL"), a leading provider and developer of advanced personal telemedicine solutions, announced today the updated agenda of the Special General Meeting of the Shareholders that will be held on May 3, 2018 at 13:00 p.m. (Israel Time), at the Company's registered office, located at 90 Yigal Alon Street, Ashdar Building, Tel-Aviv, Israel. The agenda shall include the following matters:

1. Election of one (1) Independent (External) Director to the Board of Directors of the Company (out of five (5) candidates, pursuant to Section 239(b) of the Israeli Companies Law, 1999 (the "Companies Law"), for a three (3) year term.
   
   The Independent (external) director nominees have submitted the Company the declarations required pursuant to Sections 224b, 241(a) of the Companies Law with respect to fulfilling the legal requirements to serve as Independent (external) Director of the Company.
   
   The names of the candidates, by alphabetical order, are: (1) Ms. Ruth Gal; (2) Ms. Dvorah Kimhi; (3) Ms. Nomi Sandhaus; (4) Ms. Hava Shechter; and (5) Ms. Eti Vidavsky.
   
2. Following recommendation and approval by the Company's Compensation Committee and Board - grant of 18,000 options to the newly appointed Independent (external) Director;
   
3. Following recommendation and approval by the Company's Compensation Committee and Board - approval of an amendment to the Company's Office Holder Compensation Policy;
   
4. Following recommendation and approval by the Company's Compensation Committee and Board - approval of the terms and conditions of the employment of the Company's Chief Executive Officer, including the issuance of options;
   
5. Following recommendation and approval by the Company's Compensation Committee and Board - approval of the payment of a one-time special retirement bonus to the Company's former Chief Executive Officer;
   
   All of the above as more fully set forth in the Notice to Shareholders available on the Company's website.

The record date was set for April 23, 2018.

The invitation to the SGM shall not be published in newspapers. The full invitation to the SGM can be downloaded on http://www.shl-telemedicine.com/about-us/investorrelations/general-meeting/. The background material including the CVs and declarations of the director nominees are available on the website or in the Company's offices, or will be forwarded upon request, all as indicted in the Notice to Shareholders.

For further information, please contact:

Martin Meier-Pfister, IRF Communications, phone : +41 43 244 81 40, shl@irfcom.ch